TOP NEWS: GSK ups guidance as boosted by Shingrix and Arexvy
(Alliance News) - GSK PLC on Wednesday hailed the performance of the world's first approved respiratory syncytial virus vaccine Arexvy, as it reported a rise in profit and revenue. Read More